This year's DIA European EuroMeeting Conference programme will address a broad range of topics, including the challenges of the revised Pharmaceutical Legislation, which is the driving force for review of all aspects of regulatory achievement. The Legislation also brings many opportunities for cooperative associations among stakeholders, who will work together to successfully challenge the R&D paradigms of the past and revitalise them for the future. The objective is to develop safe, effective and quality-assured medicines that ensure public health.

Phase Forward Senior Professional Earns Lifetime Award

Phase Forward's Barry Burnstead will be honoured during the DIA Distinguished Career and Outstanding Services Award ceremony on Monday, March 6th with a lifetime membership award in acknowledgement of his active participation in the DIA.

As part of this year's conference, Barry Burnstead will be co-chair of the Data Management track (Track 12) and will chair the session titled Managing Clinical Trial and Pharmacovigilance Safety Data (Tuesday, March 7, 14:00). This session describes how the worlds of clinical data management and pharmacovigilance interface in significant ways. Serious adverse events attract equal attention from all stakeholders. Global strategies and processes need to address this common interest. Furthermore, the advent of electronic capture of clinical data from trials adds a new dynamic, impacting procedure for validating and reporting. Common interest exists in coding activities of shared data with contrasting requirements driving different solutions. However, the industry is prepared to seek out new solutions and this session looks at how two companies sponsoring trials address these challenges and provides insight into how conflicting coding requirements can be addressed.

Phase Forward Showcases Clinical Data Management and Drug Safety Solutions

Attendees are invited to visit the Phase Forward and Lincoln Technologies exhibit to learn more about the company's clinical data management and drug safety solutions, including the industry leading InForm™ EDC solution, the new Clinical Trials Signal Detection (CTSD™) product, and the WebVDME™ pharmacovigilance signal detection and signal management product. 

Phase Forward's InForm product is widely used by pharmaceutical, biotechnology and medical device companies, of all sizes and at all trial phases. The newest version of InForm, InForm ITM, offers a wide range of tools to accelerate trial   setup and administration, and provides users near-real-time access to clinical and operational data for analysis and trial management.
 

Phase Forward's Lincoln Technologies' new CTSD product allows users of InForm and Clintrial, Phase Forward's clinical data management product, to access cutting-edge technology for safety signal detection during clinical trials. CTSD               offers techniques for detecting potential safety problems early in the pre-marketing clinical trials stage. CTSD incorporates signal detection algorithms that address adverse events and the safety effects of different doses across demographic strata such as age, gender and race using lab, ECGs and other relevant data.
 

Phase Forward's Lincoln Technologies' WebVDME product was recently implemented by the Medicines and Healthcare products Regulatory Agency (MHRA), the U.K.'s regulatory agency.  MHRA clinicians, pharmacists and scientists are using WebVDME to examine reports of suspected drug side effects from medicines received through its Yellow Card Scheme, a system used to collect information on suspected adverse drug reactions.


Learn more about Phase Forward and Lincoln Technologies at Stand: 108–110

For media inquiries, please contact Kevin Payne of De Facto Communications at +44 (0)20 7861 3023.

News

Applied Clinical Trials-03-06-2006

Phase Forward Senior Professional Barry Burnstead Honored with Membership Lifetime Award